These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 12019156

  • 1. Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu.
    Hewitt SC, Bocchinfuso WP, Zhai J, Harrell C, Koonce L, Clark J, Myers P, Korach KS.
    Cancer Res; 2002 May 15; 62(10):2798-805. PubMed ID: 12019156
    [Abstract] [Full Text] [Related]

  • 2. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
    Zhou H, Chen WD, Qin X, Lee K, Liu L, Markowitz SD, Gerson SL.
    Oncogene; 2001 Sep 20; 20(42):6009-17. PubMed ID: 11593408
    [Abstract] [Full Text] [Related]

  • 3. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.
    Lin SC, Lee KF, Nikitin AY, Hilsenbeck SG, Cardiff RD, Li A, Kang KW, Frank SA, Lee WH, Lee EY.
    Cancer Res; 2004 May 15; 64(10):3525-32. PubMed ID: 15150107
    [Abstract] [Full Text] [Related]

  • 4. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
    Bocchinfuso WP, Hively WP, Couse JF, Varmus HE, Korach KS.
    Cancer Res; 1999 Apr 15; 59(8):1869-76. PubMed ID: 10213494
    [Abstract] [Full Text] [Related]

  • 5. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.
    Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418
    [Abstract] [Full Text] [Related]

  • 6. Alcohol promotes mammary tumor development via the estrogen pathway in estrogen receptor alpha-negative HER2/neu mice.
    Wong AW, Dunlap SM, Holcomb VB, Nunez NP.
    Alcohol Clin Exp Res; 2012 Apr 01; 36(4):577-87. PubMed ID: 21981381
    [Abstract] [Full Text] [Related]

  • 7. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E, Li B, Anagnostopoulos AM, Coleman A, Perkins AS.
    Exp Mol Pathol; 2001 Jun 01; 70(3):183-93. PubMed ID: 11417997
    [Abstract] [Full Text] [Related]

  • 8. Effect of c-neu/ ErbB2 expression levels on estrogen receptor alpha-dependent proliferation in mammary epithelial cells: implications for breast cancer biology.
    Shyamala G, Chou YC, Cardiff RD, Vargis E.
    Cancer Res; 2006 Nov 01; 66(21):10391-8. PubMed ID: 17079459
    [Abstract] [Full Text] [Related]

  • 9. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
    Rudolph-Owen LA, Chan R, Muller WJ, Matrisian LM.
    Cancer Res; 1998 Dec 01; 58(23):5500-6. PubMed ID: 9850086
    [Abstract] [Full Text] [Related]

  • 10. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.
    Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E.
    Cancer Res; 2007 Sep 15; 67(18):8671-81. PubMed ID: 17875707
    [Abstract] [Full Text] [Related]

  • 11. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
    Zinser GM, Welsh J.
    Carcinogenesis; 2004 Dec 15; 25(12):2361-72. PubMed ID: 15333467
    [Abstract] [Full Text] [Related]

  • 12. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
    Yoshidome K, Shibata MA, Couldrey C, Korach KS, Green JE.
    Cancer Res; 2000 Dec 15; 60(24):6901-10. PubMed ID: 11156389
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
    Sacco MG, Barbieri O, Piccini D, Noviello E, Zoppé M, Zucchi I, Frattini A, Villa A, Vezzoni P.
    Gene Ther; 1998 Mar 15; 5(3):388-93. PubMed ID: 9614559
    [Abstract] [Full Text] [Related]

  • 14. Use of mouse mammary tumour virus (MMTV)/neu transgenic mice to identify genes collaborating with the c-erbB-2 oncogene in mammary tumour development.
    Jolicoeur P, Bouchard L, Guimond A, Ste-Marie M, Hanna Z, Dievart A.
    Biochem Soc Symp; 1998 Mar 15; 63():159-65. PubMed ID: 9513720
    [Abstract] [Full Text] [Related]

  • 15. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
    Nguyen A, Rosner A, Milovanovic T, Hope C, Planutis K, Saha B, Chaiwun B, Lin F, Imam SA, Marsh JL, Holcombe RF.
    Int J Oncol; 2005 Oct 15; 27(4):949-56. PubMed ID: 16142310
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of Muc1 in MMTV-c-Neu tumors.
    Adriance MC, Gendler SJ.
    Oncogene; 2004 Jan 22; 23(3):697-705. PubMed ID: 14737104
    [Abstract] [Full Text] [Related]

  • 17. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
    Krane IM, Leder P.
    Oncogene; 1996 Apr 18; 12(8):1781-8. PubMed ID: 8622899
    [Abstract] [Full Text] [Related]

  • 18. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.
    Cadieux C, Kedinger V, Yao L, Vadnais C, Drossos M, Paquet M, Nepveu A.
    Cancer Res; 2009 Sep 15; 69(18):7188-97. PubMed ID: 19738070
    [Abstract] [Full Text] [Related]

  • 19. Involvement of Notch1 in the development of mouse mammary tumors.
    Diévart A, Beaulieu N, Jolicoeur P.
    Oncogene; 1999 Oct 28; 18(44):5973-81. PubMed ID: 10557086
    [Abstract] [Full Text] [Related]

  • 20. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
    Ursini-Siegel J, Rajput AB, Lu H, Sanguin-Gendreau V, Zuo D, Papavasiliou V, Lavoie C, Turpin J, Cianflone K, Huntsman DG, Muller WJ.
    Mol Cell Biol; 2007 Sep 28; 27(18):6361-71. PubMed ID: 17636013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.